Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Lianluo Smart (LLIT) Competitors

LLIT vs. ICAD, TMDIF, APYX, NVNO, MODD, TELA, DXR, HSAQ, FEMY, and MDAI

Should you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include iCAD (ICAD), Titan Medical (TMDIF), Apyx Medical (APYX), enVVeno Medical (NVNO), Modular Medical (MODD), TELA Bio (TELA), Daxor (DXR), Health Sciences Acquisitions Co. 2 (HSAQ), Femasys (FEMY), and Spectral AI (MDAI).

Lianluo Smart vs.

iCAD (NASDAQ:ICAD) and Lianluo Smart (NASDAQ:LLIT) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, community ranking, analyst recommendations and institutional ownership.

Lianluo Smart has lower revenue, but higher earnings than iCAD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iCAD$19.61M4.49-$4.85M-$0.21-15.33
Lianluo Smart$380K23.16-$4.45MN/AN/A

24.6% of iCAD shares are owned by institutional investors. Comparatively, 28.8% of Lianluo Smart shares are owned by institutional investors. 10.3% of iCAD shares are owned by company insiders. Comparatively, 22.9% of Lianluo Smart shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

iCAD received 124 more outperform votes than Lianluo Smart when rated by MarketBeat users. However, 70.27% of users gave Lianluo Smart an outperform vote while only 60.80% of users gave iCAD an outperform vote.

CompanyUnderperformOutperform
iCADOutperform Votes
228
60.80%
Underperform Votes
147
39.20%
Lianluo SmartOutperform Votes
104
70.27%
Underperform Votes
44
29.73%

In the previous week, iCAD had 12 more articles in the media than Lianluo Smart. MarketBeat recorded 12 mentions for iCAD and 0 mentions for Lianluo Smart. iCAD's average media sentiment score of 0.03 beat Lianluo Smart's score of 0.00 indicating that iCAD is being referred to more favorably in the media.

Company Overall Sentiment
iCAD Neutral
Lianluo Smart Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iCAD
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Lianluo Smart
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

iCAD has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Comparatively, Lianluo Smart has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500.

Lianluo Smart has a net margin of 0.00% compared to iCAD's net margin of -17.81%. Lianluo Smart's return on equity of 0.00% beat iCAD's return on equity.

Company Net Margins Return on Equity Return on Assets
iCAD-17.81% -15.65% -12.52%
Lianluo Smart N/A N/A N/A

Summary

Lianluo Smart beats iCAD on 8 of the 14 factors compared between the two stocks.

Get Lianluo Smart News Delivered to You Automatically

Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LLIT vs. The Competition

MetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$8.80M$4.04B$5.30B$7.34B
Dividend YieldN/A39.51%5.12%4.30%
P/E RatioN/A27.6821.8617.80
Price / Sales23.1647.06380.5497.75
Price / CashN/A51.0838.2634.64
Price / Book-6.755.816.453.98
Net Income-$4.45M$67.09M$3.22B$247.81M

Lianluo Smart Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LLIT
Lianluo Smart
N/A$3.98
+5.9%
N/A+418.8%$8.80M$380,000.000.006
ICAD
iCAD
0.2364 of 5 stars
$1.69
-0.9%
N/A+106.4%$46.52M$19.61M-13.08140Analyst Downgrade
Short Interest ↑
News Coverage
Gap Up
TMDIF
Titan Medical
N/A$0.39
+7.3%
N/A+743.5%$44.82M$17.63M-0.3150Gap Up
APYX
Apyx Medical
1.2756 of 5 stars
$1.10
+10.4%
N/A-25.0%$41.38M$48.10M-1.32270
NVNO
enVVeno Medical
N/A$2.20
-3.1%
N/A-49.0%$38.49MN/A-1.7019
MODD
Modular Medical
0.7063 of 5 stars
$0.91
+14.1%
N/A-47.8%$37.62MN/A-1.7520Short Interest ↑
Negative News
TELA
TELA Bio
1.967 of 5 stars
$0.94
-4.1%
$7.25
+671.3%
-81.5%$37.03M$69.30M-0.56120Short Interest ↑
Gap Down
DXR
Daxor
4.0225 of 5 stars
$7.50
+0.7%
$25.00
+233.3%
-22.9%$36.28M$2.13M0.0037Short Interest ↓
News Coverage
HSAQ
Health Sciences Acquisitions Co. 2
N/A$2.76
-11.3%
N/A-38.1%$30.95MN/A0.004
FEMY
Femasys
1.9444 of 5 stars
$1.13
-1.7%
$11.50
+917.7%
-4.6%$30.68M$1.63M-1.4030
MDAI
Spectral AI
2.1872 of 5 stars
$1.21
+2.1%
$4.75
+294.2%
-35.1%$28.01M$29.58M-1.8583Short Interest ↑
Gap Up

Related Companies and Tools


This page (NASDAQ:LLIT) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners